LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
63.64
+0.56 (0.89%)
Dec 17, 2025, 10:13 AM EST - Market open
LivaNova Market Cap
LivaNova has a market cap or net worth of $3.48 billion as of December 17, 2025. Its market cap has increased by 21.90% in one year.
Market Cap
3.48B
Enterprise Value
3.28B
1-Year Change
21.90%
Ranking
Category
Stock Price
$63.64
Market Cap Chart
Since October 19, 2015, LivaNova's market cap has increased from $3.42B to $3.48B, an increase of 1.75%. That is a compound annual growth rate of 0.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 3.44B | 36.97% |
| Dec 31, 2024 | 2.51B | -9.78% |
| Dec 29, 2023 | 2.79B | -6.24% |
| Dec 30, 2022 | 2.97B | -36.12% |
| Dec 31, 2021 | 4.65B | 44.63% |
| Dec 31, 2020 | 3.22B | -11.87% |
| Dec 31, 2019 | 3.65B | -18.02% |
| Dec 31, 2018 | 4.45B | 15.57% |
| Dec 29, 2017 | 3.85B | 75.67% |
| Dec 30, 2016 | 2.19B | -24.35% |
| Dec 31, 2015 | 2.90B | -15.10% |
| Oct 19, 2015 | 3.42B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 943.99B |
| Johnson & Johnson | 504.27B |
| AbbVie | 395.31B |
| UnitedHealth Group | 302.73B |
| AstraZeneca | 281.22B |
| Novartis AG | 259.57B |
| Merck & Co. | 243.91B |
| Abbott Laboratories | 220.59B |